L886-0022 Screening compound: 3-{5-cyclobutanecarbonyl-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl}-5-(ethylsulfanyl)-4-methyl-4H-1,2,4-triazole

L886-0022 Screening compound: 3-{5-cyclobutanecarbonyl-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl}-5-(ethylsulfanyl)-4-methyl-4H-1,2,4-triazole
L886-0022 Screening compound: 3-{5-cyclobutanecarbonyl-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl}-5-(ethylsulfanyl)-4-methyl-4H-1,2,4-triazole alternative view

Chemical Structure Depiction of ChemDiv screening compound L886-0022
3-{5-cyclobutanecarbonyl-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl}-5-(ethylsulfanyl)-4-methyl-4H-1,2,4-triazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L886-0022

Molecular Formula

C17H24N6OS (C17 H24 N6 OS)

Compound Name

3-{5-cyclobutanecarbonyl-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl}-5-(ethylsulfanyl)-4-methyl-4H-1,2,4-triazole

IUPAC name

3-{5-cyclobutanecarbonyl-1-methyl-1H4H5H6H7H-pyrazolo[43-c]pyridin-3-yl}-5-(ethylsulfanyl)-4-methyl-4H-124-triazole

SMILES

CCSc1nnc(-c2nn(C)c(CC3)c2CN3C(C2CCC2)=O)n1C

InChI

InChI=1S/C17H24N6OS/c1-4-25-17-19-18-15(21(17)2)14-12-10-23(16(24)11-6-5-7-11)9-8-13(12)22(3)20-14/h11H,4-10H2,1-3H3

InChI Key

LGLUSQFFQZTPNJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD28120194

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

360.48

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

0.854

Distribution Coefficient, logD

0.830

Water Solubility, LogSw

-1.11

Polar Surface Area

57.173

Acid Dissociation Constant (pKa)

22.25

Base Dissociation Constant (pKb)

6.16

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

64.70

L886-0022 in Drug Discovery

Included in Screening Libraries

CNS MPO Library (28609 compounds)

GPCR Targeted Library (31838 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Ion Channels Focused Library (26372 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Nervous system
  • Cardiovascular
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with L886-0022 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L886-0022?
Check Price and Availability of L886-0022, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L886-0022 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L886-0022
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L886-0022
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L886-0022 available by request